1,008 results on '"Gudasheva, T. A."'
Search Results
52. Deficit of Neurotrophins in Experimental Diabetes – Correction with a Proline-Containing Dipeptide
53. Synthesis and In Vitro Neuroprotective Activity of Analogs with Various Spacer Lengths of a Dimeric Dipeptide Mimetic (GK-2) of Nerve Growth Factor
54. Synthesis and Cardiotropic Activity of Linear Methoxyphenyltriazaalkanes
55. Synthesis of 4-Phenylpyrrolidone Derivatives with Anticonvulsant and Nootropic Activity
56. Anti-Ischemic Activity of Triamine ALM-802 under Conditions of Endothelial Dysfunction
57. Development and Study of Anxiolytic Effect of Gml-1 Tablet Dosage Form
58. Synthesis and Anticonvulsant Activity of 4-Amino-3-Nitro-1-Thiocoumarins and 4-Amino-3-Nitroquinolin-2-Ones
59. Effect of Endogenous Neuropeptide Cycloprolylglycine on GABAA Receptors in Cerebellar Purkinje Cells
60. Synthesis and Anticonvulsant Activity of N-Substituted 4-Amino-3-Nitrocoumarins
61. A Novel Dipeptide Ligand of TSPO
62. Synthesis and Biological Properties of a New Dipeptide Mimetic of Brain-Derived Neurotrophic Factor Loop 2**
63. Synthesis and In Vitro Neuroprotector Activity of Diastereoisomers of a Dimeric Dipeptide Mimetic of Nerve Growth Factor GK-2
64. PHARMACOGENETIC ANALYSIS OF THE INTERACTION OF THE LOW-MOLECULAR WEIGHT BDNF MIMETIC DIPEPTIDE GSB-106 WITH TRK RECEPTORS
65. A New Component in the Mechanism of Regulation of Endogenous Depressive-Like States
66. Dipeptide Mimetic of the BDNF Loop 4 Possesses Analgetic Activity
67. Drug with Neuroprotective Properties Noopept Does Not Stimulate Cell Proliferation
68. Structure–Activity (Antihypoxic) Relationship in a Series of Substituted Glyprolines
69. Antidiabetic Properties of Low-Molecular-Weight BDNF Mimetics Depend on the Type of Activation of Post-Receptor Signaling Pathways
70. Synthesis and Anticonvulsive Activity of 3- and 4-Benzoylpyridine Oxime Derivatives
71. Design, Synthesis, and Pharmacological Activity of a New Matrix Metalloproteinase-9 Inhibitor
72. Comparison of the Pharmacological Effects of Dimeric Dipeptide Nerve Growth Factor Mimetic GK-2 and Mexidol on the Model of Ischemic Stroke in Rats
73. The difference in efficacies of TrkA activation mediates antiapoptotic properties of NGF small dipeptide mimetic
74. Antidepressant Effect of a Dipeptide Brain-Derived-Neurotrophic-Factor Mimetic (GSB-106) in a Generic Oral Dosage Form
75. Dipeptide Mimetic of the BDNF GSB-106 with Antidepressant-Like Activity Stimulates Synaptogenesis
76. A novel dimeric dipeptide mimetic of the BDNF selectively activates the MAPK-Erk signaling pathway
77. Design, synthesis, and neuroprotective effects of a dimeric dipeptide mimetic of the third loop of the nerve growth factor
78. Antiangiogenic Effects of Nerve Growth Factor Loop 4 Monomeric Dipeptide Mimetic
79. N-Phenylacetylglycyl-L-Proline Ethyl Ester Converts into Cyclo-L-Prolylglycine Showing a Similar Spectrum of Neuropsychotropic Activity
80. Dipeptide Mimetic of the Brain-derived Neurotrophic Factor Prevents Impairments of Neurogenesis in Stressed Mice
81. Novel Pyrrolo[1,2-a]Pyrazines (TSPO Ligands) with Anxiolytic Activity Dependent on Neurosteroid Biosynthesis
82. Preclinical Pharmacokinetic and Pharmacodynamic Studies of Pharmaceutical Compositions of the Dipeptide Anxiolytic GB-115
83. Angiogenic Effects of Dimeric Dipeptide Mimetic of Loop 4 of Nerve Growth Factor
84. Pharmacological Correction of Alcohol Motivation Depends on the Phenotype of the Response to Emotional Stress
85. Dependence of anxiolytic effects of the dipeptide TSPO ligand GD-23 on neurosteroid biosynthesis
86. Neuropeptide cycloprolylglycine increases the levels of brain-derived neurotrophic factor in neuronal cells
87. Neuropeptide cycloprolylglycine is an endogenous positive modulator of AMPA receptors
88. Synthesis of GK-2, a Dimeric Dipeptide Nerve Growth Factor Mimetic and Potential Neuroprotective Agent
89. The first dipeptide ligand of translocator protein: Design and anxiolytic activity
90. Theoretical grounds and technologies for dipeptide drug development
91. Dipeptide Piracetam Analogue Noopept Improves Viability of Hippocampal HT-22 Neurons in the Glutamate Toxicity Model
92. Neuropeptide Cycloprolylglycine Exhibits Neuroprotective Activity after Systemic Administration to Rats with Modeled Incomplete Global Ischemia and in In Vitro Modeled Glutamate Neurotoxicity
93. Dipeptide BDNF mimetic GSB-106 prevents depression-like behavior and cognitive impairment caused by ischemic stroke in rats
94. P.0864 Novel pyrrolo[1,2-a]pyrazines TSPO ligands ameliorate SH-SY5Y cells survival upon lipopolysaccharide-induced cell damage
95. P.0742 Nootropic effects of the brain neurotrophic factor dipeptide mimetic GSB-214 in models of Alzheimer's disease
96. Noopept Normalizes Parameters of the Incretin System in Rats with Experimental Diabetes
97. Synthesis and Antiarrhythmic Activity of N-[2-(1-Adamantylamino)-2-Oxoethyl]-N-(Aminoalkyl)Nitrobenzamides
98. Nerve growth factor novel dipeptide mimetic GK-2 selectively activates TrkA postreceptor signaling pathways and does not cause adverse effects of native neurotrophin
99. Study of structure-activity relationship among similar analogues of GSB-106, a dipeptide mimetic of a brain-derived neurotrophic factor
100. Synthesis of N1-(2,3,4-trimethoxybenzyl)-N2-{2-[(2,3,4-trimethoxybenzyl)amino]ethyl}-1,2-ethanediamine Organic Salts and their Cardiotropic Activity.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.